Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Amyloid protein may be transmitted through neurosurgical instruments, study suggests

Amyloid beta pathology - protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.

15 Feb 2018

New scanning technology could reduce number of biopsies on people with fatty liver disease

A study jointly led by the University of Birmingham and University of Edinburgh has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease.

13 Feb 2018

Researchers describe human blood-nerve barrier transcriptome for the first time

Human peripheral nerves -- all the nerves outside of the central nervous system -- are protected by the blood-nerve barrier. This is a tight covering of endothelial cells that maintains the microenvironment within the nerves by restricting the amounts or types of water, ions, solutes and nutrients that can reach the axons, or electric cables within the nerves, from the blood circulation system.

8 Feb 2018

German researchers find way to accurately differentiate prostate cancer from benign tissue

Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine.

6 Feb 2018

Early and targeted treatment of dnDSA preserves allograft function

Development of de novo donor-specific antibodies (dnDSA) is known to cause graft failure. Therefore, a protocol aimed at prospective monitoring and treating dnDSA--before it can cause graft damage--was developed for kidney transplant recipients at Children National Health System.

5 Feb 2018

Researchers evaluate need for biopsies during follow-up care for breast cancer patients

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care.

31 Jan 2018

Researchers turn to new biomarkers for predicting organ transplant rejection

Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.

31 Jan 2018

Expert panel releases updated guidelines for lung cancer molecular testing

Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease. This makes detecting these genetic alterations an essential step in diagnosis.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).

27 Jan 2018

Leading medical societies update molecular testing guideline for lung cancer

Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide.

24 Jan 2018

Analysis finds overlooked crucial factor in determining prognosis for DIPGs

The prognosis for all children diagnosed with an aggressive brain tumor known as diffuse intrinsic pontine glioma and similar tumors has been mostly the same: dismal.

18 Jan 2018

When you need a breast screening, should you get a 3-D mammogram?

When I went to the imaging center for my regular mammogram last year, the woman behind the desk asked me if I'd like to get a "3-D" mammogram instead of the standard test I'd had in the past.

16 Jan 2018

Novel polygenic hazard score captures age variations of aggressive prostate cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.

12 Jan 2018

Research provides insights into mechanisms governing healthy longevity

Keio University Global Research Institute, Tokyo publishes the January 2018 issue of KGRI Research Frontiers that includes researcher video profiles of Keio University researchers and research highlights from high impact publications including 'Regenerative medicine needs collaboration in and out of science in order to face current and future challenges; ‘Does eating fish protect you from depression?’; ‘Insights into the molecular mechanisms leading to kidney dysfunction in diabetic patients’; and ‘Ageing to 100 and beyond: Insights from demographic, phenotypic and genetic studies.

12 Jan 2018

Computer model based on AI improves analysis of kidney biopsies

The ability to quantify the extent of kidney damage and predict the life remaining in the kidney, using an image obtained at the time when a patient visits the hospital for a kidney biopsy, now is possible using a computer model based on artificial intelligence.

11 Jan 2018

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

A new blood stabilization method, developed at the Massachusetts General Hospital Center for Engineering in Medicine, significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells (CTCs), living cancer cells carried in the bloodstream.

9 Jan 2018

FDA issues approval letter for Planmed Clarity 2D digital mammography system

The United States Food and Drug Administrationissued an approval letter for the Planmed Clarity 2D full-field digital mammography system on December 28th, 2017.

8 Jan 2018

New article demonstrates potential, feasibility of PlaqueTec Liquid Biopsy System to detect biomarkers for CAD

PLAQUETEC LTD today announced the publication of the first peer‐reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System™ to detect biomarkers for coronary artery disease (CAD).

5 Jan 2018

Biopsy News and Research

Further Reading

Amyloid protein may be transmitted through neurosurgical instruments, study suggests

New scanning technology could reduce number of biopsies on people with fatty liver disease

Researchers describe human blood-nerve barrier transcriptome for the first time

German researchers find way to accurately differentiate prostate cancer from benign tissue

Early and targeted treatment of dnDSA preserves allograft function

Researchers evaluate need for biopsies during follow-up care for breast cancer patients

Researchers turn to new biomarkers for predicting organ transplant rejection

Expert panel releases updated guidelines for lung cancer molecular testing

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Leading medical societies update molecular testing guideline for lung cancer

Analysis finds overlooked crucial factor in determining prognosis for DIPGs

When you need a breast screening, should you get a 3-D mammogram?

Novel polygenic hazard score captures age variations of aggressive prostate cancer

Research provides insights into mechanisms governing healthy longevity

Computer model based on AI improves analysis of kidney biopsies

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

FDA issues approval letter for Planmed Clarity 2D digital mammography system

New article demonstrates potential, feasibility of PlaqueTec Liquid Biopsy System to detect biomarkers for CAD

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News